On July 10, 2025, the U.S. Food and Drug Administration (FDA) announced that it was embracing “radical transparency” by publishing more than 200 Complete Response Letters (CRLs) — letters the agency issues to a sponsor when...more
8/26/2025
/ Capital Markets ,
Disclosure Requirements ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Pharmaceutical Industry ,
Publicly-Traded Companies ,
Regulatory Authority ,
Regulatory Oversight ,
Regulatory Requirements ,
Risk Management ,
Securities and Exchange Commission (SEC) ,
Securities Litigation
Increases in Counterfeit Beauty and Personal Care Products -
The rise of e-commerce has led to increasing sales of counterfeit or noncompliant beauty and personal care products, including many that are knockoffs of...more
In March 2024, Valisure, an independent quality advocate, filed a citizen petition claiming to have detected elevated levels of benzene in benzoyl peroxide acne treatment products. Valisure’s petition included testing results...more
3/28/2025
/ Class Action ,
Cosmetics ,
Food and Drug Administration (FDA) ,
Healthcare ,
Insurance Industry ,
Life Sciences ,
Manufacturers ,
Personal Care Products ,
Regulatory Requirements ,
Risk Management ,
Third-Party ,
Toxic Chemicals